Pharmaceutical giant Eli Lilly announces a massive $3.5 billion investment in a new Pennsylvania manufacturing facility dedicated to next-generation weight-loss drugs, signaling a long-term strategic commitment to the obesity market amid intense competition.
Japanese apparel retailer Shimamura (TSE:8227) has completed a massive share repurchase program and reshuffled its executive team in a concentrated two-day move, signaling a strategic pivot to boost per-share metrics and long-term value.
Merck & Co. shares have delivered impressive multi-year returns, climbing over 80% in the past five years. Yet, a deep dive into its valuation metrics suggests the market may still be underestimating the pharmaceutical leader's intrinsic value, presenting a potential opportunity for investors.
ServiceNow accelerates its push into real-world AI automation, expanding key partnerships and retooling its global partner ecosystem to embed AI agents directly into enterprise workflows, as the company seeks to translate AI investment into tangible business value under investor pressure.
U.S. stock futures retreated Monday as investors parsed a mixed bag of global manufacturing data, raising fresh questions about the durability of corporate earnings against a backdrop of cooling factory activity in key European economies.
A new poll shows the centre-right Tisza party maintaining an eight-point advantage over the ruling Fidesz, setting the stage for Hungary's most consequential vote in over a decade, with major implications for Europe's political landscape.
French IT giant Capgemini initiates the sale of its U.S. federal subsidiary, Capgemini Government Solutions, attributing the move to restrictive oversight rules for classified contracts and a desire for strategic focus.
The global professional services firm Aon posted a net income of $1.7 billion for the final quarter of 2025, fueled by robust growth in its commercial risk and reinsurance divisions, while full-year revenue climbed 9% to $17.2 billion.
As financial institutions grapple with aging core systems like Gen, experts warn that deferring modernization in hopes of a future AI fix is compounding costs, risks, and missed opportunities in a rapidly evolving digital landscape.
A wave of international reinsurance giants, including Lloyd's of London, Samsung Re, and Mapfre Re, are seeking approval to set up shop in India's GIFT IFSC, drawn by tax incentives and a booming market, as the hub aims to rival established global financial centers.
Global logistics firm GXO will close its Romeoville, Illinois plant this April, citing evolving business needs. The move, announced under state WARN Act requirements, eliminates 32 positions, though the company says affected workers may apply for roles at other sites.
While analyst price targets often paint a rosy picture, a closer look reveals a more nuanced reality. We examine one favored stock with solid fundamentals and two others where the Street's optimism may be overlooking critical risks.
While a net cash position often signals financial resilience, it can also mask underlying weaknesses in growth and profitability. We examine three companies where ample cash on hand fails to translate into compelling investment cases, and explore what investors should look for instead.
As several prominent stocks test 52-week lows, investors face a critical choice: identify oversold opportunities or steer clear of troubled names. We analyze one company showing signs of a turnaround and two where caution may be warranted.
While growth often requires investment, a sustained negative free cash flow can signal deep-seated issues. We examine three well-known companies where the cash burn warrants a cautious approach from investors.
Mazda Motor Corporation's global vehicle production saw a significant rebound in December 2025, offering a positive end to a year where overall output and sales declined. The recovery was driven by strong domestic performance and a mixed picture overseas.
Shares of the direct-to-consumer telehealth company Hims & Hers have been halved over the past six months, trading near $27. Investors are now weighing whether the steep sell-off presents a buying opportunity or signals deeper troubles ahead.
While OceanFirst Financial (OCFC) has kept pace with the market, analysts highlight concerns over its weak net interest income growth, modest earnings expansion, and a projected decline in tangible book value. The search for value shifts focus elsewhere.
Fulton Financial (FULT) shares have surged 16% in six months, outpacing the S&P 500. While the rally is impressive, a closer look at its fundamentals reveals potential headwinds in revenue growth, profitability, and book value expansion, prompting some analysts to suggest investors consider rotating capital elsewhere.
The third-quarter earnings season revealed a stark divergence in performance among leading healthcare technology providers. While Omnicell impressed with strong results and a soaring stock, peers like Evolent Health and Astrana Health faced significant market headwinds despite revenue beats.
